Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyRadiation DosageAntineoplastic AgentsCisplatinRadiation, IonizingRadiation InjuriesTreatment OutcomeCyclophosphamideDoxorubicinDose-Response Relationship, RadiationNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsRadiation ToleranceNeoplasm StagingEtoposideSurvival AnalysisDrug Administration ScheduleRadiationSurvival RatePrognosisLung NeoplasmsRadiation MonitoringMethotrexateRadiotherapyRadiation ProtectionCarboplatinPaclitaxelNeoplasm Recurrence, LocalNeoplasmsVinblastineRadiotherapy DosageInduction ChemotherapyTaxoidsIfosfamideDrug Resistance, NeoplasmBleomycinTime FactorsDeoxycytidineAntimetabolites, AntineoplasticRadiotherapy, AdjuvantOrganoplatinum CompoundsFollow-Up StudiesAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungSalvage TherapyRadiation OncologyAnthracyclinesAdenocarcinomaCytarabineNeoplasm MetastasisChemotherapy, Cancer, Regional PerfusionBrain NeoplasmsOvarian NeoplasmsHodgkin DiseaseVomitingLymphoma, Non-HodgkinNeutropeniaAntineoplastic Agents, PhytogenicNauseaTesticular NeoplasmsRadiation PneumonitisTransplantation, AutologousProspective StudiesDacarbazineClinical Trials as TopicColorectal NeoplasmsNeoplasms, Radiation-InducedAntibiotics, AntineoplasticRadiometryRadiation Injuries, ExperimentalDose FractionationCosmic RadiationKaplan-Meier EstimateInfusions, IntravenousCell Line, TumorCarmustineLomustineBone NeoplasmsCamptothecinGamma RaysCarcinoma, Squamous CellNeoplasms, Germ Cell and EmbryonalGranulocyte Colony-Stimulating FactorLeukopeniaInfusions, Intra-ArterialChemoradiotherapyLiver NeoplasmsOsteosarcomaRecurrencePlatinum CompoundsHead and Neck NeoplasmsMelphalanAntiemeticsTumor Markers, BiologicalPalliative CareDose-Response Relationship, DrugLymphatic Metastasis